Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about BCL2 inhibitors: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Knowledge base pages for this entity
| Target | Relation | Type | Str |
|---|---|---|---|
| apoptosis | promotes | process | 0.95 |
| chronic lymphocytic leukaemia | treats | disease | 0.92 |
| relapsed or refractory CLL | treats | disease | 0.90 |
| progression-free survival | promotes | phenotype | 0.88 |
| relapsed/refractory mantle cell lymphoma | treats | disease | 0.85 |
| mantle cell lymphoma | treats | disease | 0.85 |
| Source | Relation | Type | Str |
|---|---|---|---|
| BTK inhibitors | combined_with | drug | 0.85 |
| BTK inhibitors | associated_with | drug | 0.80 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||